Sort
16,300 grants matching “fatty liver disease”
Regulation of Mitochondrial Metabolism by Post-Translational Modifications
$301,611David J Pagliarini · Morgridge Institute For Research, Inc. · R01 · FY2017 · DK
Regulation of Mitochondrial Metabolism by Post-Translational Modifications
$301,611David J Pagliarini · Morgridge Institute For Research, Inc. · R01 · FY2016 · DK
Time-restricted feeding and breast cancer
$301,592Nicholas J Webster · University Of California, San Diego · R01 · FY2024 · CA
eIF2A in translational control
$301,582Anton A. Komar · Cleveland State University · R01 · FY2020 · GM
"Glycosphingoiipids,Giycosyltransferases and Cardiovascular disease"
$301,570Subroto Babul Chatterjee · Johns Hopkins University · P01 · FY2012 · HL
Microbiome as therapeutic target in alcoholic hepatitis
$301,538Bernd G. Schnabl · University Of California, San Diego · U01 · FY2022 · AA
Microbiome as therapeutic target in alcoholic hepatitis
$301,538Bernd G. Schnabl · University Of California, San Diego · U01 · FY2020 · AA
Microbiome as therapeutic target in alcoholic hepatitis
$301,538Bernd G. Schnabl · University Of California, San Diego · U01 · FY2021 · AA
Reduction in CVD risk in children by physical activity
$301,533Robert C Hickner · East Carolina University · R01 · FY2007 · DK
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$301,458Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Inflammation, HDL and class B Scavenger Rectors
$301,444Deneys Rem Van Der Westhuyzen · University Of Kentucky · P01 · FY2007 · HL
Role of estrogen-related receptors in cardiac and skeletal muscle
$301,412Janice M Huss · Beckman Research Institute/City Of Hope · R01 · FY2008 · DK
Lipoproteins and Microbial Immunity
$301,275Hobart Whitaker Harris · University Of California, San Francisco · R01 · FY2010 · GM
Roles of GM-CSF in Energy and Glucose Regulation
$301,272Randy J. Seeley · University Of Cincinnati · R01 · FY2010 · DK
Development of Conjugated Oligonucleotide Therapeutics for Neuronal Disease
$301,212Arthur Thomas Suckow · Dtx Pharma, Llc · R43 · FY2019 · TR
Regulation of Fatty Acid Oxidation during ER stress: mechanisms and consequences
$301,188David Thomas Rutkowski · University Of Iowa · R01 · FY2018 · GM
Regulation of Fatty Acid Oxidation during ER stress: mechanisms and consequences
$301,188David Thomas Rutkowski · University Of Iowa · R01 · FY2016 · GM
Regulation of Fatty Acid Oxidation during ER stress: mechanisms and consequences
$301,188David Thomas Rutkowski · University Of Iowa · R01 · FY2017 · GM
Core C: Atherosclerosis and bioinformatics core
$301,110Jenny E. Kanter · University Of Washington · P01 · FY2025 · HL
Inborn Errors of Long Chain Fat Metabolism
$301,066Gerard Vockley · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · DK
Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis
$301,025Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2020 · DK
Gut regulation of bariatric surgery-induced bone loss
$301,000Ziru Li · Mainehealth · P20 · FY2023 · GM
Potential Mechanisms of Glucagon-like peptide-1 in Fatty Liver Disease
$300,967Frank A. Anania · Emory University · R01 · FY2009 · DK
PUFA Synthesis and the Control of Hepatic Metabolism
$300,961Donald B Jump · Oregon State University · R01 · FY2013 · DK
LIPIN 1 IN THE REGULATION OF HEPATIC LIPID METABOLISM
$300,960Brian N Finck · Washington University · R01 · FY2010 · DK